,38 Evaluation of the role of genetically proxied GLP1R signaling, alone and in combination with genetically proxied GIPR signaling, could provide additional insight into the viability of dual pharmacological GLP1R/GIPR agonism for breast cancer prevention. This evidence concerns the gene GIPR and breast cancer.